Joshua Cohen is a Boston-based writer who covers health policy. Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback